Member Info for GordonGecko123

Davey enjoy tour agl losses. Sad individual who can't get over he's a loser.

That's what full recommendation will be. You really are desperate aren't you system zero. I'm glad your missing out here couldn't have happened to a more deserving fool

The reason for the extenuom is to devise a rollout plan for the NHS. To me that says the recommendation is a done deal and the rollout will be rapid once it's announced. That's how I read it anyway..

As for the takeover possibility I don't usually count on them as they are pretty rare and often people mention them to try and ramp the sp in desperation but here I do feel there is a better than average chance of it simply because the mkt cap is so low and what this company had to offer.

Bonzo there has always been M&a activity in biotech sector especially when UK mkt caps are depressed as they are now. What u think makes this more likely is the amaericna partner assisting the fda process. They may well look to acquire Gdr just on the usa market basis alone. There are also other companies in the usa and abroad that see an spoourtunity to grab a unique product that's fully developed and potential other uses for peanuts compared to what it's true value is.

The market cap here is simply too low for what it has and although its sales are currently minor with NICE this will grow rapidly.

Bonzo yes we do 10p is only 54m mkt cap which is nothing for a company with 2 sale teadybpeofuctsvand recurring revenue streams in various markets worldwide.

You obviously didn't read my earlier post on the NICE delay news so I'm. Not going to spell it out for you but your just lazy and ill informed like mammy traders and chnacers. More fool you, please don't bother buying we are better of with intelligent people investing here not gamblers

Unfortubtaley like many other small biotechs apta is struggling with its cash position and will require further funding in the near future. Whilst the increase in revenues from recent deals is welce and a good sign that the business had a future it's not enough for the company to break even before the cash runs out. Initial projections from the company were for this to happen in August but this may have been extended slightly with the new deals. Renmeber though not all the monies from those deals will be recognised straight away but spread out over the length of the deal.

With this in mind apta will need to raise funds in the near future and in this market that will result in the sp falling substantially from where it is today. Most companies have suffered a 50-75% discount to raise modest amounts of cash namely Polx, Gdr, sce, Avacta, etc etc. I suspect a similar event is coming here and likely explains the lack of share price rise on the recent run of good news. Whilst I like the company and progress it's making until this happens the shares are unlikely to rise, infcat more likely to fall as that event apooraches.

I suspect a fund raise in the region of 0.3p will be what happens and hopefully they raise around 3m to help them get to breakeven. When it happens I will look to buy shares in apta.

Maybe you should go back to the agl thread where your doing ever so well. Oh wait no your not your sat on losses there.

4p is 20m mkt cap with 6m in the bank. And you wonder why it's still rising. The valuation is far to low and it's just returning to a fairer valuation compared to other companies

Your right there davey. I bet you didn't email NICE to find out did you. I've been in here from 1.5p and held and continue to hold over 1.6m shares thanks but keep talking. Your right tou don't know anything we agree on that.

Dave I've only just managed to sign up here. I've been on advfn for 22 years though. At 17m mkt cap I would hardly calls this as a pump m it's undervalued but please continue to talk dribble it hasn't stopped you before

I do agree that American conpanies may well look at Gdrs potential. And make a bid for Gdr in the near future the potential and cheap valuation would make it a bargain given the development is done alrwsdy. Weather it comes before or after the NICE approval or weather today's rns is the catalyst for that who knows.

For me it has a good chance of being bought out now

He can't do that as it would be insider trading. They are in a closed period due to news pending and today's rns. The window for directors to buy is usually quite small. I wouldn't be surprised to see directors take options though.

Do people on here know the reason for the delay to the NICE recommendation date.?

Several people emailed NICE and the reply they got was the delay is to allow for a implementation plan to be drawn up for the NHS.

That to me says the test has been recommended and being prepped to be rolled out nationally. Dyor

3.6p mkt cap 17m think where this is heading

Let the weak exit for their small profits. I've set a target and not selling may until it hits that. Chartist say target 1 6 p, target 2 14p.

6p is 30m mkt cap with 6m in the bank. This is worth a lot more than that tbh and we are only jjust past half way to that.

Even now the mkt cap is only 17m with 6m in cash in the bank and 2 fully developed tests about to be implemented into the NHS. This has a lot higher to go yet